DaVita (DVA) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Jan 29, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Berkshire Hathaway Inc, 10% Owner sold 382,563 shares at $180.43 ($69.0M).
- Trade date
- Oct 27, 2026
- Disclosed to the SEC
- Oct 29, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All DVA insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
DVA insider transactions (Form 4)
Open-market purchases and sales. 82 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 29SEC | Berkshire Hathaway Inc10% Owner | Sell | 382,56328,314,666 held (−1%) | $180.43 | $69.0M | -13.6% | — |
| Aug 4SEC | Berkshire Hathaway Inc10% Owner | Sell | 182,98028,697,229 held (−1%) | $199.55 | $36.5M | -21.9% | — |
| Jun 17SEC | Javier RodriguezCEO | Sell | 39,407840,408 held (−4%) | $209.28 | $8.2M | -25.5% | — |
| Jun 17SEC | Javier RodriguezCEO | Sell | 30,000879,815 held (−3%) | $209.50 | $6.3M | -25.6% | — |
| Jun 17SEC | Kathleen Alyce WatersGeneral Counsel | Sell Plan | 8,950115,649 held (−7%) | $207.84 | $1.9M | -25.0% | — |
| Jun 17SEC | Kathleen Alyce WatersGeneral Counsel | Sell Plan | 6,455109,194 held (−6%) | $209.17 | $1.4M | -25.4% | — |
| May 18SEC | James O. HeartyChief Compliance Officer | Sell | 15,00022,389 held (−40%) | $193.98 | $2.9M | -19.6% | — |
| May 13SEC | David Paul MaughanCOO | Sell | 13,45694,105 held (−13%) | $199.25 | $2.7M | -21.7% | — |
| May 13SEC | David Paul MaughanCOO | Sell | 7,073107,561 held (−6%) | $199.15 | $1.4M | -21.7% | — |
| May 11SEC | Joel AckermanCFO | Sell | 51,471132,434 held (−28%) | $192.10 | $9.9M | -18.8% | — |
| May 8SEC | James O. HeartyChief Compliance Officer | Sell Plan | 2,18435,953 held (−6%) | $174.87 | $382K | -10.8% | — |
| May 5SEC | Berkshire Hathaway Inc10% Owner | Sell | 1,220,37628,880,209 held (−4%) | $149.84 | $183M | +4.1% | — |
| Feb 2SEC | Berkshire Hathaway Inc10% Owner | Sell | 1,658,48030,100,585 held (−5%) | $120.56 | $200M | +29.4% | — |
| Oct 29SEC | Berkshire Hathaway Inc10% Owner | Sell | 401,51431,759,065 held (−1%) | $135.36 | $54.3M | +15.2% | — |
Similar past setups: not applicable. DVA has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with DVA in the Research Lab
DVA has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
DaVita insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 6 sold $523M of DVA stock on the open market; P/E 15.1 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
DVA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $69.0M | 1 |
| Q3 2026 | — | 0 | $36.5M | 1 |
| Q2 2026 | — | 0 | $218M | 10 |
| Q1 2026 | — | 0 | $200M | 1 |
| Q4 2025 | — | 0 | $54.3M | 1 |
Valuation, profit and volume
Source: Yahoo Finance, as of Oct 5, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 DaVita insiders reported open-market purchases totaling $0, while 6 insiders reported sales totaling $523M. Among insiders with enough purchase history to measure, Wendy Lee Schoppert (Director) has the highest Insider Score at 96. 3 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
DVA earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Oct 29, 2026 | +1.0% | Sold $69.0M | +1.9%S&P -2.1% | pending |
| Aug 4, 2026 | -1.4% | Sold $36.5M | -19.3%S&P +1.6% | -2.5% |
| May 5, 2026 | +4.2% | Sold $183M | +25.8%S&P +2.2% | -0.9% |
| Feb 2, 2026 | +3.3% | Sold $200M | +23.2%S&P -0.4% | +11.3% |
| Oct 29, 2025 | +4.6% | Sold $54.3M | -8.4%S&P -1.1% | +0.8% |
| Aug 5, 2025 | -1.2% | None | -8.4%S&P +0.3% | +7.9% |
| May 12, 2025 | +3.0% | None | +0.2%S&P +4.0% | -4.6% |
| Feb 13, 2025 | -0.7% | None | -8.5%S&P +1.1% | -8.9% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
DVA short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded DVA
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +1.0% |
Insiders at DaVita
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Berkshire Hathaway Inc10% Owner | — | $543M | Oct 29, 2026 | 0 of 1 | — |
| Javier RodriguezCEO | — | $14.5M | Nov 17, 2026 | — | — |
| Joel AckermanCFO | — | $9.9M | May 11, 2026 | — | — |
| David Paul MaughanCOO | — | $4.1M | Sep 24, 2026 | — | — |
| James O. HeartyChief Compliance Officer | — | $3.3M | May 18, 2026 | — | — |
| Kathleen Alyce WatersGeneral Counsel | — | $3.2M | Jun 17, 2026 | — | — |
| Christopher Michael BerryChief Accounting Officer | — | — | Nov 17, 2026 | 0 of 1 | — |
| Phyllis R. YaleDirector | — | — | Nov 17, 2026 | — | — |
| Wendy Lee SchoppertDirector | — | — | Nov 17, 2026 | — | 96 |
| Dennis W. PullinDirector | — | — | Nov 17, 2026 | — | — |
| Adam H. SchechterDirector | — | — | Nov 17, 2026 | — | — |
| Jason M. HollarDirector | — | — | Nov 17, 2026 | — | — |
| Gregory J. MooreDirector | — | — | Nov 17, 2026 | — | — |
| Barbara J. DesoerDirector | — | — | Nov 17, 2026 | — | — |
| Pamela M. ArwayDirector | — | — | Nov 17, 2026 | — | — |
Board links: companies that share insiders with DVA
Directors and executives who filed Form 4s for DVA and another company in the last 12 months.
- CAHCardinal Health Jason M. Hollar Director here · CEO at CAH · latest filing Nov 17, 2026
- FOSLFossil Group Wendy Lee Schoppert Director here · Director at FOSL · latest filing Nov 17, 2026
- FTVFortive Gregory J. Moore Director here · Director at FTV · latest filing Nov 17, 2026
- GILDGilead Sciences Javier Rodriguez CEO here · Director at GILD · latest filing Nov 17, 2026
- IRMIron Mountain Pamela M. Arway Director here · Director at IRM · latest filing Nov 17, 2026
- LHLabcorp Adam H. Schechter Director here · CEO, President at LH · latest filing Nov 17, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
DVA stock: common questions
Are DaVita insiders buying DVA stock?
No. No DaVita insider reported an open-market purchase of DVA in the past 12 months.
Are DaVita insiders selling DVA stock?
6 insiders reported sales worth $523M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is DVA's P/E ratio?
DVA trades at about 15.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is DVA's 52-week range?
Over the past year DVA has traded between $103.87 and $240.96. It last closed at $155.94 on Nov 19, 2026.